Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and immunogenicity of concomitant sIPV and DTaP vaccination in infants
ChiCTR2100041758Phase 4Completed
- Sponsor
- Shaanxi Provincial Center for Disease Control and Prevention
- Start
- Aug 2019
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of trivalent inactivated polio vaccine and diphtheria, tetanus, and acellular pertussis vaccine in poliomyelitis, pertussis, diphtheria and 1 more (3 arms), sponsored by Shaanxi Provincial Center for Disease Control and Prevention. Primary endpoints: Geometric mean titres, Seroconversion rate and 1 more. Started Aug 2019; status: completed.
02
Drugs
trivalent inactivated polio vaccinediphtheria, tetanus, and acellular pertussis vaccine
03
Conditions
poliomyelitispertussisdiphtheriaTetanus
Beyond the preview
Go deeper on ChiCTR2100041758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100041758.